Evidence-basedEditor-reviewedCited sourcesUpdated regularly
Botanicals & Herbs

Boswellia (Frankincense)

Also known as: Boswellia serrata, Indian frankincense, Boswellic acids

The anti-inflammatory resin — boswellic acids with genuine osteoarthritis data and an arthritis-adjacent niche.

In short

Boswellia is the gum resin of the frankincense tree — the same material burned in temples for millennia — whose boswellic acids turned out to be a selective anti-inflammatory chemistry: they inhibit 5-lipoxygenase, an enzyme in the inflammatory cascade, with a mechanism distinct from NSAIDs. The clinical record is respectable for a botanical: trials and meta-analyses find boswellia extracts reduce pain and improve function in osteoarthritis, with effects building over weeks and a good safety profile. It is one of the better-supported natural options for joint inflammation, with secondary niches in asthma and inflammatory bowel conditions.

  • Gum resin of Boswellia serrata — frankincense
  • Boswellic acids inhibit 5-lipoxygenase (anti-inflammatory)
  • Meta-analyses: reduced osteoarthritis pain and stiffness
  • Distinct mechanism from NSAIDs — generally well tolerated

What is Boswellia (Frankincense)?

Boswellia's journey from temple incense to clinical anti-inflammatory is one of the cleaner translations in herbal medicine: the same resin that perfumed ancient rituals contains boswellic acids that block a specific enzyme in the inflammatory cascade — 5-lipoxygenase — through a mechanism NSAIDs do not touch. The clinical literature has followed the chemistry into the joint clinic, where boswellia extracts show real, if modest, improvements in osteoarthritis pain and function. It occupies the growing natural-anti-inflammatory niche alongside curcumin, with its own evidence base and a notably clean safety profile.

Where it comes from

Natural sources

  • Gum resin of Boswellia serrata, native to India; related species grow across the Horn of Africa and Arabia
  • Boswellic acids — pentacyclic triterpenes — are the active fraction
  • Used in Ayurvedic medicine for arthritis and inflammation for centuries

How it's made

Sold as resin extracts standardized to boswellic-acid content (typically 30–65%); AKBA (acetyl-11-keto-β-boswellic acid) is the key active marker.

What it does in products

  • Inhibits 5-lipoxygenase — the leukotriene inflammatory pathway
  • Reduces cartilage-degrading enzyme activity in laboratory models
  • Modulates inflammatory cytokines
  • Traditional support for joint, respiratory, and gut inflammation

Benefits

Osteoarthritis

strong evidence

Meta-analyses of randomized trials find boswellia reduces osteoarthritis pain and stiffness and improves function versus placebo, with effects comparable to some NSAIDs in short trials and better tolerability.

Inflammatory bowel conditions

moderate evidence

Small trials in ulcerative colitis and collagenous colitis report symptom improvements — promising, limited data.

Asthma

emerging evidence

Its leukotriene inhibition is the same pathway targeted by prescription asthma drugs, and small trials show modest benefit — consistent but preliminary.

Side effects & safety

Stomach upset or reflux (uncommon)Usually mild; take with food.
Loose stools (rare)Dose-related.

Safety considerations

  • Avoid in pregnancy — traditional cautions and insufficient data.
  • May add to anti-inflammatory effects of NSAIDs and anticoagulants (theoretical); no firmly established interactions.
  • Not for: Pregnancy
  • Not for: Known allergy to frankincense resin

How it's used

In supplements

Osteoarthritis studies used 100–500 mg of standardized extract (often AKBA-enriched) once or twice daily for 8–12 weeks. Look for products stating boswellic-acid or AKBA content.

Regulatory status

  • Dietary supplement under DSHEA and traditional food use; no drug approval.
  • GRAS (generally recognized as safe) for food use.

Popular products containing Boswellia (Frankincense)

  • Boswellia ExtractNOW Foods · Supplement
  • 5-LOXIN (AKBA-enriched boswellia)Life Extension · Supplement
  • Boswellia SerrataSwanson · Supplement

Product names and brands are shown for reference and belong to their respective owners.

A different anti-inflammatory pathway: why boswellia pairs with NSAIDs

Inflammation runs through several enzyme cascades, and boswellia's value proposition is that it hits one the standard drugs miss. NSAIDs block cyclooxygenase (COX); boswellic acids block 5-lipoxygenase, the enzyme producing leukotrienes — a parallel inflammatory route. The clinical consequence is practical: boswellia's side-effect profile avoids the gastric and kidney issues of NSAIDs, and the two mechanisms can complement each other in combination strategies. The caveat is potency: boswellia's effects are gentler and slower-building. It is not an NSAID replacement for severe pain, but a legitimate, mechanism-distinct option for chronic joint inflammation.

Frequently asked questions

Does boswellia work for arthritis?

Yes, modestly — pooled trials show real reductions in osteoarthritis pain and stiffness over 8–12 weeks. It is slower and gentler than NSAIDs but much better tolerated, making it a reasonable chronic-use option.

What does AKBA mean on a boswellia label?

Acetyl-11-keto-β-boswellic acid — the most active boswellic acid. Products standardized to AKBA content (like 5-LOXIN) deliver the studied active more reliably than raw resin powders.

Is boswellia the same as frankincense essential oil?

Same tree, different products: boswellia supplements use the resin's boswellic acids for internal anti-inflammatory effects, while frankincense essential oil is aromatic and used topically or in aromatherapy. They are not interchangeable.

The bottom line

Boswellia is a genuinely mechanism-distinct natural anti-inflammatory — 5-lipoxygenase inhibition with meta-analysis support for osteoarthritis. Choose AKBA-standardized extracts, dose for 8–12 weeks, and treat it as a chronic-care adjunct rather than a fast-acting painkiller.

References

  1. Boswellia and osteoarthritis (meta-analysis). PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=boswellia+osteoarthritis+meta-analysis
  2. Boswellic acids and 5-lipoxygenase — literature search. PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=boswellic+acid+5-lipoxygenase
  3. Boswellia and ulcerative colitis — literature search. PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=boswellia+ulcerative+colitis
  4. Boswellic acid compound records. PubChem (National Library of Medicine). https://pubchem.ncbi.nlm.nih.gov/#query=boswellic%20acid